Abstract
Adenoviruses are non-enveloped linear double-stranded DNA viruses with over 100 types in humans. Adenovirus vectors have gained tremendous attention as gene delivery vehicles, as vaccine vectors and as oncolytic viruses. Although various methods have been used to generate adenoviral vectors, the vector-producing process remains technically challenging regarding efficacious genome modification. Based on our previously reported adenoviral genome modification streamline via linear–circular homologous recombination, we further develop an HEHR (combining Homing Endonucleases and Homologous Recombination) method to engineer adenoviral genomes more efficiently. I-PpoI, a rare endonuclease encoded by a group I intron, was introduced into the previously described ccdB counter-selection marker. We found that the I-PpoI pre-treatment of counter-selection containing parental plasmid increased the homologous recombination efficiency up to 100%. The flanking of the counter-selection marker with either single or double I-PpoI sites showed enhanced efficacy. In addition, we constructed a third counter-selection marker flanked by an alternative restriction enzyme: AbsI, which could be applied in case the I-PpoI site already existed in the transgene cassette that was previously inserted in the adenovirus genome. Together, HEHR can be applied for seamless sequence replacements, deletions and insertions. The advantages of HEHR in seamless mutagenesis will facilitate rational design of adenoviral vectors for diverse purposes.
Funder
Witten/Herdecke University
DFG
Subject
Genetics (clinical),Genetics
Reference46 articles.
1. Journal of Gene Medicine (2022, November 09). Vectors Used for Gene Transfer in Gene Therapy Clinical Trials. Available online: https://a873679.fmphost.com/fmi/webd/GTCT.
2. Human Adenovirus Working Group (2022, November 09). Human Adenovirus Types. Available online: http://hadvwg.gmu.edu/.
3. Getting genetic access to natural adenovirus genomes to explore vector diversity;Virus Genes,2017
4. Zhang, W., Mese, K., Schellhorn, S., Bahlmann, N., Mach, N., Bunz, O., Dhingra, A., Hage, E., Lafon, M.E., and Wodrich, H. (2020). High-Throughput Cloning and Characterization of Emerging Adenovirus Types 70, 73, 74, and 75. Int. J. Mol. Sci., 21.
5. Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D;J. Virol.,2007
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献